The CareStart COVID-19 ANTIGEN TEST is a lateral flow immunochromatographic assay for rapid detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare providers. No additional equipment or instruments are required for this test.
Additional Information
FDA Emergency Use Authorization Information

